Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | VHL | P40337 | 1/20 | 0.50 |
| ▸ | ELOC | Q15369 | 1/20 | 0.50 |
| ▸ | ELOB | Q15370 | 1/20 | 0.50 |
| ▸ | AOC2 | O75106 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.43 |
| ▸ | GRK2 | P25098 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7128290 | 0.93 | CYP3A4 (0.52) | MAPTLMNAKDM4EGAANPSR1 | |
| SCHEMBL20253478 | 0.87 | ALDH1A1 (0.58) | MAPTLMNAKDM4EGAANPSR1 | |
| SCHEMBL78611 | 0.77 | KMT2A (0.53) | MAPTLMNAKDM4EGAANPSR1 | |
| SCHEMBL44284 | 0.73 | KDM4E (0.50) | MAPTKDM4EGAANPSR1L3MBTL1 | |
| SCHEMBL599252 | 0.72 | VHL (0.56) | MAPTLMNAKDM4EGAANPSR1 | |
| SCHEMBL5547132 | 0.72 | KDM4E (0.50) | MAPTLMNAKDM4EGAANPSR1 | |
| SCHEMBL11822364 | 0.72 | KDM4E (0.50) | MAPTKDM4EGAANPSR1L3MBTL1 | |
| SCHEMBL393880 | 0.72 | KDM4E (0.50) | MAPTKDM4EGAANPSR1L3MBTL1 | |
| SCHEMBL196307 | 0.72 | NOTUM (0.52) | MAPTLMNAKDM4EGAANPSR1 | |
| SCHEMBL1260035 | 0.72 | KDM4E (0.50) | MAPTLMNAKDM4EGAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117542666-A | Porous ordered graphene/polypyrrole covalent composite supercapacitor electrode material and preparation method and application thereof | 华南理工大学 | 2024-02-09 | — | — | CN | claimed |
| CN-110790535-B | Maintenance method of asphalt road | 广东高翔建设有限公司 | 2021-07-06 | — | — | CN | claimed |
| CN-110105336-B | Viologen derivative electrochromic material and preparation method thereof | 华南理工大学 | 2020-09-22 | — | — | CN | claimed |
| US-10566106-B2 | Conjugated polymer coatings and methods for atmospheric plasma deposition thereof | THE BOEING COMPANY (US) | 2020-02-18 | — | — | US | claimed |
| CN-110790535-A | Maintenance method of asphalt road | 广东高翔建设有限公司 | 2020-02-14 | — | — | CN | claimed |
| CN-110105336-A | Viologen derivative electrochromic material and preparation method thereof | 华南理工大学 | 2019-08-09 | — | — | CN | claimed |
| US-20160049226-A1 | CONJUGATED POLYMER COATINGS AND METHODS FOR ATMOSPHERIC PLASMA DEPOSITION THEREOF | THE BOEING COMPANY | 2016-02-18 | — | — | US | claimed |
| US-20080207694-A1 | Hydroxamates as Histone Deacetylase Inhibitors and Pharmaceutical Formulations Containing Them | ROSSI CRISTINA | 2008-08-28 | — | — | US | claimed |
| EP-1868997-A1 | HYDROXAMATES AS HISTONE DEACETYLASE INHIBITORS AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM | Menarini International Operations Luxembourg S.A. (LU) | 2007-12-26 | — | — | EP | claimed |
| WO-2006097460-A1 | HYDROXAMATES AS HISTONE DEACETYLASE INHIBITORS AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM | MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. (LU) | 2006-09-21 | — | — | WO | claimed |
| CN-85106344-A | Use contains the imaging system of the photosensitive microcapsules of 4-(4 '-aminophenyl)-pyridine compounds | — | 1987-02-18 | — | — | CN | claimed |
| US-12391781-B2 | Black particles, black coating material, coating film, and black matrix for color filters | SEKISUI CHEMICAL CO., LTD. (JP) | 2025-08-19 | — | — | US | disclosed |
| CN-120398828-A | Red light delayed fluorescent material based on naphthalimide, and preparation method and application thereof | 大连理工大学 | 2025-08-01 | — | — | CN | disclosed |
| EP-4063426-B1 | BLACK PARTICLES, BLACK COATING MATERIAL, COATING FILM, AND BLACK MATRIX FOR COLOR FILTERS | SEKISUI CHEMICAL CO LTD (JP) | 2025-06-18 | — | — | EP | disclosed |
| CN-120081789-A | Pyrazole derivative with antitumor activity and preparation method and application thereof | 天津匠新致成科技有限公司 | 2025-06-03 | — | — | CN | disclosed |
| EP-1080092-A2 | BICYCLIC PYRIMIDINES AND BICYCLIC 3,4-DIHYDROPYRIMIDINES AS INHIBITORS OF CELLULAR PROLIFERATION | WARNER-LAMBERT COMPANY (US) | 2001-03-07 | — | — | EP | disclosed |
| WO-2001005393-A2 | METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-01-25 | — | — | WO | disclosed |
| WO-2000041505-A2 | ANTHRANILIC ACID DERIVATIVES | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-1999061444-A2 | BICYCLIC PYRIMIDINES AND BICYCLIC 3,4-DIHYDROPYRIMIDINES AS INHIBITORS OF CELLULAR PROLIFERATION | WARNER-LAMBERT COMPANY (US) | 1999-12-02 | — | — | WO | disclosed |
| US-4617316-A | Insecticidal heteroaryl substituted phenyl benzoylureas | FMC CORPORATION (US) | 1986-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207694-A1 | Hydroxamates as Histone Deacetylase Inhibitors and Pharmaceutical Formulations Containing Them | HDAC1, HDAC8, HDAC9 | MAPT 791/4885LMNA 1681/4885KDM4E 183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.